Concepedia

Author

Ingrid Louw

Cape Town Science CentreORCID

Also Known As

H. I. Huppertz, I Louw, I. Louw, Ingrid C Louw, Ingrid Louw, Mahmood Ally

33

Publications

831

Citations

11

H-Index

7

Concepts

All Affiliations

Cape Town Science CentreSchön Klinik Hamburg EilbekUCLouvainHôpital LapeyronieMerck & Co., Inc., Rahway, NJ, USA (United States)
IL

About

Ingrid Louw is an author at Cape Town Science Centre specializing in clinical trials, rheumatic diseases, and rheumatology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

479

2

Pharmacology

1

1

479

3

Rheumatology

1

1

479

4

Clinical Trials

1

1

479

5

Rheumatic Diseases

1

1

479

Ingrid Louw

×

8

Publications

732

Citations

8

H-Index

YearCitations

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall,

The Lancet

2017

479

Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study)

Jeffrey Kaine, Geoffrey Gladstein, Ingrid Strusberg,

Annals of the Rheumatic Diseases

2011

73

Subcutaneous Abatacept in Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis

Hermine I. Brunner, Nikolay Tzaribachev, Gabriel Vega‐Cornejo,

Arthritis & Rheumatology

2018

67

Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study

Bernard Combe, Bhaskar Dasgupta, Ingrid Louw,

Annals of the Rheumatic Diseases

2013

31

Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis

Nicolino Ruperto, Hermine I. Brunner, César Pacheco‐Tena,

Lara D. Veeken

2021

30

Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab

Nathan Vastesaeger, Abraham García Kutzbach, Howard Amital,

Lara D. Veeken

2016

25

OP0226 Randomized, Double-Blind Study Comparing Chs-0214 with Etanercept in Patients with Active Rheumatoid Arthritis (RA) despite Methotrexate (MTX) Therapy

James R. O’Dell, Tsutomu Takeuchi, Yoshiya Tanaka,

Annals of the Rheumatic Diseases

2016

14

Patient and Physician Expectations of Add‐On Treatment With Golimumab for Rheumatoid Arthritis: Relationships Between Expectations and Clinical and Quality of Life Outcomes

Bhaskar Dasgupta, Bernard Combe, Ingrid Louw,

Arthritis Care & Research

2014

13

Page 1